Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism p38 MAPK inhibitors(P38 mitogen-activated protein kinase inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H15FN4O |
InChIKeyADQZGIYHFQQPRB-UHFFFAOYSA-N |
CAS Registry215306-39-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | US | 07 Oct 1998 | |
Psoriasis | Preclinical | US | 07 Oct 1998 | |
Rheumatoid Arthritis | Preclinical | US | 07 Oct 1998 |